£23m pharmaceutical centre creating 50 jobs opens in Hull
New laboratory development facility for pharmaceutical company INDIVIOR
By Hull Daily Mail | Posted: 23 Aug 2017
A new £23m research and development centre for an international pharmaceutical firm has opened in west Hull.
Indivior have officially opened the new laboratory development, which will become the centre for their research operations nationally.
The major investment has also seen the creation of 50 highly skilled jobs at the industry-leading facility in Henry Boot Way.
The centre will house research and innovation into drugs that help people battle with addiction.
The company’s core product, buprenorphine, used to treat opioid addiction and chronic pain, was discovered by the company, whose heritage in Hull dates back to 1966.
Shaun Thaxter, chief executive officer of Indivior, said: “This new state-of-the-art centre is an investment in our mission to pioneer life-transforming treatments for patients struggling with addiction.
“Indivior’s focus on the needs of patients can be traced back decades, to the days before buprenorphine was discovered, right here in Hull, and developed as a treatment for opioid addiction.
“Our hope is this centre will help us further our leadership in the development of treatment approaches that deliver on the unmet needs of patients suffering from addiction.”
The CEO, who previously worked in Hull under Dr Chris Chapleo, after whom the new building is named, said he was proud to return to the city and has created a site ready for further expansion.
He said: “The history that the company has with Hull meant that it has always been somewhere we have associated with innovation.
“We’ve returned and are really glad to do so with this cutting edge technology plant, with 50 employees with highly skilled jobs.
“I used to work in Hull and we felt very fondly of the city. We have extra land around the site deliberately so if we need to reconfigure in the future we can expand.
“We wanted to ensure there was a platform for growth, so we are ready for the next ten to 15 years. This will global business for around the world that will be directing from the centre here in Hull.”
The facility is equipped with millions of pounds worth of scientific technology, including a 400MHz Nuclear Magnetic spectrometer, which is used to study the structure of molecules.
The centre has been built to environmental and energy saving standards, with a solar panel farm and electric car charging spaces for members of staff.
Indivior say their vision is to ensure all patients around the world will have access to quality treatment for addiction disorders, including alcohol use disorder and schizophrenia.
Emma Hardy, MP for Hull West & Hessle, said: “I’m delighted that Indivior has chosen to locate its world-class R&D facility in Hull.
“This will serve as a real boost for our community and affirms the city of Hull as a great place to do business.”
Celebrating the Energy Estuary: Humber Renewables Awards shortlist is revealed